Article Information
History
- April 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Haley E. Mudrick1,
- Erin B. McGlinch2,
- Brian J. Parrett2,3,
- Jack R. Hemsath2,
- Mary E. Barry4,
- Jeffrey D. Rubin3,
- Chisom Uzendu3,
- Michael J. Hansen5,
- Courtney L. Erskine5,
- Virginia P. VanKeulen5,
- Aleksandra Drelich6,
- Chien-Te Kent Tseng6,7,
- Shane Massey8,
- Madiha Fida4,
- Gina A. Suh4,
- Tobias Peikert5,9,10,
- Matthew S. Block5,9,
- Gloria R. Olivier11 and
- Michael A. Barry4,5,12,#
- 1Molecular Pharmacology and Experimental Therapeutics (MPET) Graduate Program, Mayo Clinic, Rochester, MN
- 2Graduate Research Education Program (GREP), Mayo Clinic, Rochester, MN
- 3Virology and Gene Therapy (VGT) Graduate Program, Mayo Clinic, Rochester, MN
- 4Department of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, MN
- 5Department of Immunology, Mayo Clinic, Rochester, MN
- 6Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX
- 7Center of Biodefense and Emerging Disease, University of Texas Medical Branch, Galveston, TX
- 8Institutional Office or Regulated Nonclinical Studies, University of Texas Medical Branch, Galveston, TX
- 9Department of Medical Oncology, Mayo Clinic, Rochester, MN
- 10Department of Medicine, Division of Pulmonary Care, Mayo Clinic, Rochester, MN
- 11Mayo Clinic Ventures, Mayo Clinic, Rochester, MN
- 12Department of Molecular Medicine, Mayo Clinic, Rochester, MN
- ↵#Correspondence to:
Michael A. Barry, PhD. Mayo Clinic, 200 First Street SW, Rochester, MN, USA. Tel: 507-266-9090, E-mail: mab{at}mayo.edu